The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the immediate withdrawal, suspension, and cancellation of 101 pharmaceutical products.
The food and drug regulator said that these pharmaceutical products are no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria.
This disclosure is contained in a statement issued by NAFDAC on its X (formerly Twitter) official handle on Tuesday, September 30, 2025, where it stated that the list of these products can be accessed on its website.
The list covers hundreds of items across medicines and health products from antimalarials (various artemether/lumefantrine formulations) and cardiovascular drugs (valsartan products) to insulin/growth-hormone injectables (Norditropin), diabetes medicines (Januvia/Janumet), inhalers and eye drops.
The list includes some widely used drugs like Abacavir tablets, Amaryl tablets, Aprovasc tablets, Artemether/Lumefantrine, ASAQ(Artesunate amodiaquine Winthrop) 100mg/270mg Tablets, ASAQ(Artesunate amodiaquine Winthrop) 25mg/67.5mg Tablets, Combination 3 Tablets, Amlodipine, among many others.
The products are from some well-known pharmaceutical companies like Sanofi Aventis Nigeria ltd, Novartis Nigeria Limited, Bayer East Africa Limited, Healthline Limited, Fensyl MHP Consulting Ltd, and many others.
The complete list of the 101 products and the pharmaceutical companies can be seen on their website.
(Nairametrics)
